Anti-MED24 monoclonal antibody

Pre-made anti-MED24 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MED24/MED24 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1163-Ab-1/ GM-Tg-hg-IP1163-Ab-2Anti-Human MED24 monoclonal antibodyHuman
GM-Tg-rg-IP1163-Ab-1/ GM-Tg-rg-IP1163-Ab-2Anti-Rat MED24 monoclonal antibodyRat
GM-Tg-mg-IP1163-Ab-1/ GM-Tg-mg-IP1163-Ab-2Anti-Mouse MED24 monoclonal antibodyMouse
GM-Tg-cynog-IP1163-Ab-1/ GM-Tg-cynog-IP1163-Ab-2Anti-Cynomolgus/ Rhesus macaque MED24 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1163-Ab-1/ GM-Tg-felg-IP1163-Ab-2Anti-Feline MED24 monoclonal antibodyFeline
GM-Tg-cang-IP1163-Ab-1/ GM-Tg-cang-IP1163-Ab-2Anti-Canine MED24 monoclonal antibodyCanine
GM-Tg-bovg-IP1163-Ab-1/ GM-Tg-bovg-IP1163-Ab-2Anti-Bovine MED24 monoclonal antibodyBovine
GM-Tg-equg-IP1163-Ab-1/ GM-Tg-equg-IP1163-Ab-2Anti-Equine MED24 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1163-Ab-1/ GM-Tg-hg-IP1163-Ab-2; GM-Tg-rg-IP1163-Ab-1/ GM-Tg-rg-IP1163-Ab-2;
GM-Tg-mg-IP1163-Ab-1/ GM-Tg-mg-IP1163-Ab-2; GM-Tg-cynog-IP1163-Ab-1/ GM-Tg-cynog-IP1163-Ab-2;
GM-Tg-felg-IP1163-Ab-1/ GM-Tg-felg-IP1163-Ab-2; GM-Tg-cang-IP1163-Ab-1/ GM-Tg-cang-IP1163-Ab-2;
GM-Tg-bovg-IP1163-Ab-1/ GM-Tg-bovg-IP1163-Ab-2; GM-Tg-equg-IP1163-Ab-1/ GM-Tg-equg-IP1163-Ab-2
Products NameAnti-MED24 monoclonal antibody
Formatmab
Target NameMED24
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MED24 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1163-Ag-1Recombinant multi-species MED24/ ARC100/ CRSP100 protein


    Target information

    Target IDGM-IP1163
    Target NameMED24
    Gene ID9862,23989,619436,699536,480529,101094551,504613,100054553
    Gene Symbol and Synonyms911GSE,ARC100,CRSP100,CRSP4,D11Ertd307e,DRIP100,Gse2,MED24,MED5,Pparb2,Pparbp2,THRAP4,TRAP100
    Uniprot AccessionO75448,Q4V8B3
    Uniprot Entry NameMED24_HUMAN,MED24_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000008838
    Target ClassificationN/A

    The target: MED24, gene name: MED24, also named as ARC100, CRSP100, CRSP4, DRIP100, MED5, THRAP4, TRAP100. This gene encodes a component of the mediator complex (also known as TRAP, SMCC, DRIP, or ARC), a transcriptional coactivator complex thought to be required for the expression of almost all genes. The mediator complex is recruited by transcriptional activators or nuclear receptors to induce gene expression, possibly by interacting with RNA polymerase II and promoting the formation of a transcriptional pre-initiation complex. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.